039d30697b09b0d316c13505e7cf6185.jpg

Scaling composites 3D printing into a new dimension Decision Makers

by Technologies

Swiss startup 9T Labs stands out in the global 3D printing landscape for leveraging a unique process that combines extensive know-how in continuous fiber reinforced composites, additive manufacturing and tooling to target large serial production runs, across multiple market segments. Whenever a company does something unique in additive manufacturing, something that may seem too ambitious, the only way to understand its actual potential is to see it in person. After closely following 9T’s growth from the start, 3dpbm visited the company’s HQ in Zurich and spoke with Co-founder Giovanni and Yannick Willemin, Head Marketing and Business Development, to understand exactly where 9T stands today and where it’s heading, on its way to scaling composites 3D printing.

b80bf87014e9f850a2271d0180aa309e.jpg

How ‘To Grow a Building’ using seeds and soil Sustainability

by Architecture

According to a project submitted to designboom, a group of designers – Or Naim, Elisheva Gillis, Gitit Linker, Danny Freedman, Noa Zermati, Adi Segal, Rebeca Partook, and Nof Nathansohn – have created ‘To Grow a Building’, an outdoor performative lab that imagined the possibility of a world in which buildings are 3D printed from organic materials. The designers presented the project at Jerusalem Design Week 2022.

5453bfb6ae7edfc93022ecfc3456a275.jpg

Wearable biomaterial inks developed by researchers Bioprinting

by Consumer

A team of researchers at Texas A&M University has developed a new class of biomaterial inks that mimic native characteristics of highly conductive human tissue, much like skin, which are essential for the ink to be used in 3D printing. This biomaterial ink leverages a new class of 2D nanomaterials known as molybdenum disulfide (MoS2). The thin-layered structure of MoS2 contains defect centers to make it chemically active and, combined with modified gelatin to obtain a flexible hydrogel, is comparable to the structure of Jell-O.

f77db8804ae25e6d8ce9b40d0936e8cb.jpg

CELLINK and IISc to establish a Centre of Excellence in India Bioprinting

by Medical

CELLINK, a global leader in developing 3D bioprinters, and The Indian Institute of Science (IISc) are partnering to establish a Centre of Excellence (CoE) for 3D bioprinting in Bengaluru, India. The CoE, the first of its kind in the sub-continent, will be housed in the Centre for BioSystems Science and Engineering (BSSE) at IISc. The CoE will provide access to 3D bioprinting systems, enabling researchers to accelerate their work across critical applications with the ultimate goal of improving health outcomes.

8c97f8d388390a035746c1dd5e2b485e.jpg

3D Systems’ Medical Advisory Board adds two new doctors Medical

by Medical

3D Systems has appointed Dr. Toby Cosgrove, former president and chief executive officer of the Cleveland Clinic, and Dr. Bon Ku, director of the Health Design Lab at Thomas Jefferson University, as the fourth and fifth members of the company’s recently established Medical Advisory Board (MAB). Dr. Cosgrove and Dr. Ku will join former Health & Human Services Secretary Alex Azar, Dr. Stephen K. Klasko, and former US Secretary of Veterans Affairs David J. Shulkin as members of the advisory board. The Board’s primary mission is to provide strategic input, guidance, and recommendations for the company’s expanding efforts in regenerative medicine.

fde5b7abc2317ef30c1c0d32821c12fc.jpg

3D Systems’ Medical Advisory Board adds two new doctors Medical AM

by Business

3D Systems has appointed Dr. Toby Cosgrove, former president and chief executive officer of the Cleveland Clinic, and Dr. Bon Ku, director of the Health Design Lab at Thomas Jefferson University, as the fourth and fifth members of the company’s recently established Medical Advisory Board (MAB). Dr. Cosgrove and Dr. Ku will join former Health & Human Services Secretary Alex Azar, Dr. Stephen K. Klasko, and former US Secretary of Veterans Affairs David J. Shulkin as members of the advisory board. The Board’s primary mission is to provide strategic input, guidance, and recommendations for the company’s expanding efforts in regenerative medicine.